Note 7 - Warrants |
6 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2026 | ||||||||||||||||||||||||||||||||||||||||||||||
| Notes to Financial Statements | ||||||||||||||||||||||||||||||||||||||||||||||
| Warrants Disclosure [Text Block] |
7. Warrants
The activity related to warrants during the six months ended June 30, 2026, is summarized as follows:
Pre-Funded Warrants
In March 2026, the Company issued pre-funded warrants at a price of $0.585 per warrant to purchase up to an aggregate of 6,399,316 shares of common stock at an exercise price of $0.001 per share, in connection with the third closing of the April 2025 Private Placement (see Note 6, “Stockholders’ Equity” for additional information).
In April 2026, 1,828,000 pre-funded warrants at an exercise price of $0.001 per share were exercised on a cashless basis for the issuance of 1,825,478 shares of common stock.
At June 30, 2026, 23,624,768 of the 43,890,344 warrants outstanding and exercisable were pre-funded warrants. |
|||||||||||||||||||||||||||||||||||||||||||||